Published Date: 02 Mar 2023
Researchers from the Barts Cancer Institute and the Francis Crick Institute at Queen Mary University of London have discovered why patients with rare blood cancers suffer from the development of poor red blood cells and...
Read Full NewsAn AES study revealed the real-world persistence of fenfluramine in treating Lennox-Gastaut syndrome, highlighting patient demographics and treatment trends.
Final safety data from an open-label study presented at AES 2025 supported long-term fenfluramine use in pediatric and adult patients with Dravet syndrome or Lennox-Gastaut syndrome.
Low-Intensity Ultrasound Brain Stimulation Safely Reduces Depression Symptoms
Exercise May Be as Effective as Therapy for Alleviating Depression Symptoms
Parental Illness Perceptions Drive Poor QoL in Children with Food Allergies
Young Adults With Glomerular Disease May Require Distinct Care
Q4 2025 Recap: Nephrology News and Updates
1.
Antitumor mRNA-based vaccines show potential against gastric cancer metastasis
2.
Could AI plus lasers help catch very early breast cancers?
3.
Approval in Endometrial Cancer Expanded; Masks at Cancer Centers; NPR Reporter Dies
4.
Some low-grade prostate cancers carry higher risks than biopsy suggests
5.
A new therapeutic approach could help tackle radiation resistance in childhood brain tumors
1.
Navigating the Complexity of Peritoneal Carcinomatosis: A Guide for Patients and Caregivers
2.
Unleashing the Power of AI: A Systematic Review of Predictive Biomarker Discovery in Immuno-Oncology
3.
Future of Chemotherapy: New Advances, Treatments & Survival Rates Transforming Cancer Care
4.
HCC in Melanoma: Role of HCC Codes and Moderate Whole Body Hyperthermia
5.
The Benefits and Side Effects of Vidaza Syndrome
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Managing ALK+ NSCLC while Ensuring Long-Term Safety of the Patients
2.
Cost Burden/ Burden of Hospitalization For R/R ALL Patients
3.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part III
4.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VI
5.
Newer Immunotherapies for Myeloma- A Comprehensive Overview
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation